1. 1. Gelder MG, Lopez-Ibor. JJ, Andreasen N, editors. New Oxford Textbook of Psychiatry. Volume 1, 2ed. New York: Oxford university press; 2000: 567-636.
2. 2. Gosh A, Chakraborty K, Mattoo SK. Newer molecule in the treatment of schizophrenia: A clinical update. Indian journal of Pharmacology. May 2011; 43 (2): 105-112.
3. 3. Sadock BJ, Sadock VA. Kaplan and Sadock's Comprehensive textbook of psychiatry, 7th ed. USA: Lippincott Williams and Wilkins; 2000: 89.
4. 4. Lieberman AJ, Tollefson G, Tolen M, Dr. P.H, Green AI, Gur RE et al, Comparative efficacy and safety of atypical antipsychotic drugs in first-episode psychosis: A randomized, double blind trial of olanzapine versus haloperidol. American Journal of Psychiatry. 2003 Aug; 160: 1396-1404.
5. 5. Bruton LL, Lazo JS, Parker KL, editors. Goodman and Gillman's The Pharmacological Basis of Therapeutics. 10th ed. New York: McGraw hill; 2001: 485-507.